Diabetes drug maker Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) has hired bankers and lawyers to help the company find a buyer. In February Amylin turned down a $3.5 billion ($22/share) offer from Bristol-Meyers…
An anti-cholesterol drug being co-developed by Sanofi (NYSE: SNY) and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) has shown positive results in two Phase II trials the companies reported this morning. The investigational drug,…
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released the latest holdings of U.S.-listed equities as of December 31, 2011. We have included some accompanying notes on each and…
Dendreon (NASDAQ: DNDN) soared almost 40% in value, or $3.02 a share, in active trading on Thursday after announcing that fourth-quarter revenue from its Provenge prostate-cancer vaccine would exceed earlier forecasts. Looking…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Thursday morning. AstraZeneca PLC (NYSE: AZN) Cut to Underweight at JPMorgan. BlackRock,…
This last weekend brought the first waves of picks for 2012. Barron’s issued its “10 Favorite Stocks For 2012” and the stocks were just about all lower on Monday with a very…
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released the latest holdings of U.S.-listed equities as of September 30, 2011 and this is the second group of ‘L to…
Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better than analysts expected, but worries persist that the company will be hit…
The House defeated a spending bill to fund the federal government passed September 30. (Reuters) United Technologies (NYSE: UTX) will buy Goodrich (NYSE: GR) for $16.5 billion. (Reuters) China’s PMI for September…
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released the latest holdings of U.S.-listed equities as of June 30, 2011 and this is the second group of ‘M to…
Once patent protection expires on a prescription drug, the drug’s maker can take a serious beating in revenue and profitability. One way to make up for the loss is to get US…
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) is out with its new portfolio holdings as of March 31, 2011. These have been broken down into two separate groups of ‘A to L’ and…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday morning. AmerisourceBergen Corp. (NYSE: ABC) Reiterated Buy and raised target to $50…
Microsoft Corporation (NASDAQ: MSFT) is about to get beyond the somewhat negative press of the Paul Allen behind it. The software giant reports today after the close. Thomson Reuters has estimates for…
BlackRock, Inc. (NYSE: BLK) is finally getting the respect it deserves. The asset manager is being added to the S&P 500 Index. The index had held this addition up for years due…
